Lyra Therapeutics earnings were -$79.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest LYRA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$8.5M, down 22.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LYRA reported annual earnings of -$93.4M, with 49.1% growth. The next LYRA earnings date is Aug 12, 2025.
What were Lyra Therapeutics's earnings last quarter?
On LYRA's earnings call on Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q1 2025 earnings per share (EPS) of -$6.50, up 62.86% year over year. Total LYRA earnings for the quarter were -$8.55 million. In the same quarter last year, Lyra Therapeutics's earnings per share (EPS) was -$17.50.
The next LYRA earnings call is Invalid Date. Add LYRA to your watchlist to be reminded of Lyra Therapeutics's next earnings date.
Is Lyra Therapeutics profitable or losing money?
As of the last Lyra Therapeutics earnings report, Lyra Therapeutics is currently losing money. Lyra Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$79.53 million, a 15.47% increase year over year.
What was LYRA's earnings growth in the past year?
As of Lyra Therapeutics's earnings date in Invalid Date, Lyra Therapeutics's earnings has grown year over year. LYRA earnings in the past year totalled -$79.53 million.
What are Lyra Therapeutics's earnings expectations?
The current EPS estimate for Lyra Therapeutics's earnings report in Invalid Date is -$0.17.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.